ilShinbiobase Co. Ltd (068330) — Cash Flow-to-Debt Ratio
ilShinbiobase Co. Ltd (068330) has a Cash Flow-to-Debt Ratio of 0.47x as of March 2026, meaning its operating cash flow of ₩3.46 Billion could theoretically repay 0% of its total liabilities (₩7.33 Billion) in one year. For the full cash flow conversion analysis, see ilShinbiobase Co. Ltd cash conversion from operations.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ilShinbiobase Co. Ltd Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for ilShinbiobase Co. Ltd across 12 annual periods. See cash generation quality of ilShinbiobase Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.
Annual Cash Flow-to-Debt Ratio for ilShinbiobase Co. Ltd (2014–2025)
Year-by-year debt coverage analysis for ilShinbiobase Co. Ltd. Check ilShinbiobase Co. Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.39x | ₩5.27 Billion | ₩3.79 Billion | ▲ +17.7% |
| 2024 | 1.18x | ₩4.12 Billion | ₩3.49 Billion | ▼ -29.2% |
| 2023 | 1.67x | ₩5.92 Billion | ₩3.55 Billion | ▲ +191.7% |
| 2022 | 0.57x | ₩2.65 Billion | ₩4.63 Billion | ▼ -46.1% |
| 2021 | 1.06x | ₩6.74 Billion | ₩6.36 Billion | ▲ +21.8% |
| 2020 | 0.87x | ₩4.50 Billion | ₩5.17 Billion | ▼ -14.2% |
| 2019 | 1.01x | ₩5.55 Billion | ₩5.47 Billion | ▼ -20.6% |
| 2018 | 1.28x | ₩4.88 Billion | ₩3.81 Billion | ▲ +97.7% |
| 2017 | 0.65x | ₩2.11 Billion | ₩3.27 Billion | ▲ +0.5% |
| 2016 | 0.64x | ₩3.01 Billion | ₩4.68 Billion | ▲ +1162.0% |
| 2015 | 0.05x | ₩270.22 Million | ₩5.30 Billion | ▼ -94.0% |
| 2014 | 0.85x | ₩3.33 Billion | ₩3.93 Billion | — |